An in silico clinical trial, also known as a virtual clinical trial, is an individualized computer simulation used in the development or regulatory evaluation of a medicinal product, device, or intervention. While completely simulated clinical trials are not feasible with current technology and understanding of biology, its development would be expected to have major benefits over current in vivo clinical trials, and research on it is being pursued.
This report contains market size and forecasts of In Silico Clinical Trials in Global, including the following market information:
Global In Silico Clinical Trials Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global In Silico Clinical Trials market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Phase I Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of In Silico Clinical Trials include Certara, Inc., Novadiscovery Sas, Insilico Medicine, Inc., Dassault Systemes SE, GNS Healthcare Inc., The AnyLogic Company, InSilicoTrials, Immunetrics Inc. and Nuventra Pharma Sciences, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the In Silico Clinical Trials companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global In Silico Clinical Trials Market, by Phase, 2017-2022, 2023-2028 ($ millions)
Global In Silico Clinical Trials Market Segment Percentages, by Phase, 2021 (%)
Phase I
Phase II
Phase III
Phase IV
Global In Silico Clinical Trials Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global In Silico Clinical Trials Market Segment Percentages, by Application, 2021 (%)
Oncology
Infectious Disease
Hematology
Cardiology
Dermatology
Neurology
Diabetes
Others
Global In Silico Clinical Trials Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global In Silico Clinical Trials Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies In Silico Clinical Trials revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies In Silico Clinical Trials revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Certara, Inc.
Novadiscovery Sas
Insilico Medicine, Inc.
Dassault Systemes SE
GNS Healthcare Inc.
The AnyLogic Company
InSilicoTrials
Immunetrics Inc.
Nuventra Pharma Sciences
Abzena Ltd.
Siemens